Logo | Name | Σ | ||
---|---|---|---|---|
AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 959 | 787 | 130 | |
Région Auvergne-Rhône-Alpes [Automatic translation follows] #auvergnerhonealpes Auvergne-Rhône-Alpes is a large region with many assets: - With more than 8 million inhabitants, it is more populated than 13 of the 28 countries of the European Union and ranks 10th most populated region in Europe - Covering nearly 70,000 km2, or 13% of the metropolitan territory, its surface area is equivalent to that of Ireland. - In France, it is the leading industrial and gastronomic region, it ranks first for agricultural production under label (AOP, IGP, etc.) and the number of organic farms. - In Europe: it is the 8th richest region in Europe … Sectors: National and local authorities | 4304 | 3485 | 680 | |
Novacité [Automatic translation follows] The accelerator that supports innovative business creation projects with high potential Being by your side and advising you to build and develop innovative, ambitious and sustainable businesses, based on strong human values. With 30 years of experience, Novacité is today the expert center for high-potential Start-Ups of the CCI Lyon Métropole. - 367 Novacité-certified companies since 1987 - 94% of satisfied entrepreneurs - 95.6% 3-year business survival rate - 79% 6-year business survival rate Start-up, Scale-up, Business, Growth, HR, Funding, counseling, Advisor, Hypergrowth, Consultant, training, Sales, International, Successful management, Expand, and Accelerator | 106 | 17 | 87 | |
Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: French Cluster Public business cluster | 652 | 392 | 395 | |
Lyonbiopôle Auvergne-Rhône-Alpes The health innovation network As a French leading biocluster, Lyonbiopole Auvergne-Rhône-Alpes aims to federate the actors of innovation, to connect and promote them internationally and to support the emergence and development of innovative technologies, products and services to address global healthcare challenges. Lyonbiopole Auvergne-Rhône-Alpes gathers a community of more than 250 members among which world-class leaders, innovative small and medium size companies, research centers and university hospitals. At the center of this ecosystem, Lyonbiopole brings its members altogether to imagine the future of medicine and to develop breakthrough healthTech innovation available for tomorrow’s patients. Sectors: Biotechnology French Cluster Public business cluster | 460 | 262 | 268 | |
Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: Health | 2199 | 1510 | 153 | |
BFM Business [Automatic translation follows] France's leading economic and financial news channel. BFM Business TV is France's leading economic and financial news channel. It stands out for its programming focused on the search for expertise. Programs focusing on economic news have established themselves as economic news events. "Good Morning Business" for example, offers guests, the latest innovations, editorials and information on underlying trends on its set. BFM Business TV is also available live on our website as well as on a dedicated application. Tech, Stock Market, Economy, Real Estate, Business, Automobile, and High-Tech Sectors: Media | 8039 | 7217 | 889 | |
Avolta Leading Tech M&A Advisor in Europe With more than 100 deals closed in 8 years, Avolta Partners has proven to be one of the most active M&A advisors in Europe in the Tech Industry. For more information, visit www.avoltapartners.com Venture Capital, Fundraising, M&A, Corporate Finance, and Tech Sectors: Finance | 1105 | 111 | 987 | |
Resah [Automatic translation follows] For an overall performance of the purchasing and logistics function. Resah is a public interest group (GIP) whose objective is to support the pooling and professionalization of purchases in the health sector, public and private non-profit. Created in 2007 to support the pooling of hospital purchases for the Ile-de-France region, Resah opened, at the request of the DGOS, access to its markets to the national territory in 2016. It has thus become one of the major operators in the sector. It collaborates with more than 2,700 establishments in the health, medico-social and social sectors in France and … Sectors: Health | 359 | 193 | 197 | |
Digital Pharma Lab [Automatic translation follows] Leading the digital innovation in the healthcare ecosystem We are leading the digital innovation in healthcare. Our mission is to unite healthcare professionals, manufacturers, startups and institutions around digital innovation and collective intelligence. Our approach, unique in Europe, allows all the players in the healthcare ecosystem to undertake, innovate, evolve and participate every day in building the healthcare of tomorrow. Together, beyond the limits 🚀 ______________________________________________________ ______________________________________________________ A pioneer in digital innovation in the healthcare ecosystem, we are a consulting firm dedicated to digital health and the transformation of the healthcare sector through collaboration and collective intelligence. … Sectors: Health Pharmaceutical | 212 | 59 | 170 | |
Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: Bank | 12636 | 9605 | 1604 | |
Servier Pharmaceuticals Servier is a privately held international pharmaceutical company headquartered in France with a passion for innovation that has improved patients’ lives around the world. With $4.7 billion in annual sales Servier operates in almost 150 countries worldwide across five therapeutic categories including oncology, cardiovascular, immuno-inflammatory, neuroscience and diabetes. Servier is founded on the principle of serving and governed by an independent non-profit foundation. With this unique operating model, the company can be deliberate about putting patients ahead of profits. In fact, Servier re-invests 25 percent of revenue into research and development each year. Servier is committed to therapeutic progress to … Sectors: Pharmaceutical | 601 | 335 | 75 |